Suppressed Inventions and Other Discoveries by Jonathan Eisen Page B
Authors: Jonathan Eisen
Ads: Link
diseases associated with AIDS. 3
Other examples are detailed by Gallo and co-workers while discussing their adapting monkey, rat, and bird leukemia and tumor viruses for experimental use in a human (NC-37) cell line. 19 Wu, Ting and Gallo 20 discussed the synthesis of new RNA tumor viruses "induced by 5-iodo-2'deoxyuridine, IdU (a constituent of RNA) in rodent cell cultures, and noted that chemotherapy might be used to halt the reverse transcriptaselinked viral reproduction.
However, had HIV been synthesized for military purposes from various species components, it would be difficult, if not impossible, to prove. As Gillespie, Gillespie and Gallo et al. noted in 1973 concerning the origin of the RD114—another cat/human bioengineered virus—"it can always be argued that" a virus which naturally jumped species (as HIV is alleged to have done from the monkey) would be expected to have antigens that differ "from the antigen found on the viruses of known" origin. 21
LITTON BIONETICS: GALLO'S LINK TO THE DOD
Four years later, during a U.S. Senate investigation of illegal "biological testing involving Senators learned Litton Bionetics—an organization which, along with the NCI, administered and provided Dr. Gallo's research funding 10,13,15,17-19,22,26 were not only acknowledged DOD biological weapons contractors, but their affiliated Litton Systems, Inc., was among the most frequently contracted institutions involved in biological weapons research and development between 1960 and 1970 (the end of the reported period). 23 Additional biological weapons contractors with whom Dr. Gallo and/or his co-workers associated during the late 1960s and early 1970s included the University of human subjects by the
that Bionetics, Bionetics Department of Defense,"
Research Laboratories, and Chicago, 24 Texas, 13 Virginia, 25 and Yale, 17 Merck and Co. Inc., 20 and Hazelton Laboratory, site of the famous 1989 Marburg-Ebola-like (Reston) virus outbreak. 22
NCI staff reports revealed that Litton Bionetics had been granted the service contract to supply all NCI researchers, worldwide, with virtually every primate cancer research material requested, including seed viruses, viral hybrids, cell lines, experimental reagents, and African colony born monkeys including M. mulatta and C. aethiops which were associated with the major monkey AIDS virus outbreaks in California's Davis Lab, and the 1967 Marburg virus outbreaks in three European vaccine production facilities. 15-17
Litton Bionetics chief John Landon reported an experiment begun in 1965 when he inoculated 18 monkeys with rhaabdovirus simian—a rabies virus known to cause Ebola-like hemmorhagic fever in monkeys. "Nine [monkeys] died or were transferred," to allied laboratories or vaccine production facilities. This shipment was likely to have started the first hemmorhagic fever "Marburg virus" outbreak among European vaccine laboratory workers in 1967. As noted by the world's leading simian virus expert at the time, Dr. Seymour Kalter, the Marburg virus was apparently manmade. 23-25
In fact, Litton Bionetics, the chief military and industrial supplier of primates for cancer virus experimentation during the 1960s and early 1970s, also maintained the colony of the specific genus of monkeys associated with all of the major monkey AIDS virus outbreaks in the United States. 23
Through telephone interviews with Litton Bionetics and MedPath administrators, I learned that Bionetics Research Laboratories had been sold to MedPath Corporation—one of America's largest medical and blood testing laboratories—a division of Dow Corning. Dow Coming's parent, Dow Chemical Company, was also listed among the Army's chief biological weapons contractors during the 1960s and early 1970s. 26,27 Litton Bionetics, a subsidiary of Litton Industries, Inc. remains in business as a proprietor of the Frederick Cancer Research Center, a "privately owned, government contracted" facility. Bionetics, it was noted,
Other examples are detailed by Gallo and co-workers while discussing their adapting monkey, rat, and bird leukemia and tumor viruses for experimental use in a human (NC-37) cell line. 19 Wu, Ting and Gallo 20 discussed the synthesis of new RNA tumor viruses "induced by 5-iodo-2'deoxyuridine, IdU (a constituent of RNA) in rodent cell cultures, and noted that chemotherapy might be used to halt the reverse transcriptaselinked viral reproduction.
However, had HIV been synthesized for military purposes from various species components, it would be difficult, if not impossible, to prove. As Gillespie, Gillespie and Gallo et al. noted in 1973 concerning the origin of the RD114—another cat/human bioengineered virus—"it can always be argued that" a virus which naturally jumped species (as HIV is alleged to have done from the monkey) would be expected to have antigens that differ "from the antigen found on the viruses of known" origin. 21
LITTON BIONETICS: GALLO'S LINK TO THE DOD
Four years later, during a U.S. Senate investigation of illegal "biological testing involving Senators learned Litton Bionetics—an organization which, along with the NCI, administered and provided Dr. Gallo's research funding 10,13,15,17-19,22,26 were not only acknowledged DOD biological weapons contractors, but their affiliated Litton Systems, Inc., was among the most frequently contracted institutions involved in biological weapons research and development between 1960 and 1970 (the end of the reported period). 23 Additional biological weapons contractors with whom Dr. Gallo and/or his co-workers associated during the late 1960s and early 1970s included the University of human subjects by the
that Bionetics, Bionetics Department of Defense,"
Research Laboratories, and Chicago, 24 Texas, 13 Virginia, 25 and Yale, 17 Merck and Co. Inc., 20 and Hazelton Laboratory, site of the famous 1989 Marburg-Ebola-like (Reston) virus outbreak. 22
NCI staff reports revealed that Litton Bionetics had been granted the service contract to supply all NCI researchers, worldwide, with virtually every primate cancer research material requested, including seed viruses, viral hybrids, cell lines, experimental reagents, and African colony born monkeys including M. mulatta and C. aethiops which were associated with the major monkey AIDS virus outbreaks in California's Davis Lab, and the 1967 Marburg virus outbreaks in three European vaccine production facilities. 15-17
Litton Bionetics chief John Landon reported an experiment begun in 1965 when he inoculated 18 monkeys with rhaabdovirus simian—a rabies virus known to cause Ebola-like hemmorhagic fever in monkeys. "Nine [monkeys] died or were transferred," to allied laboratories or vaccine production facilities. This shipment was likely to have started the first hemmorhagic fever "Marburg virus" outbreak among European vaccine laboratory workers in 1967. As noted by the world's leading simian virus expert at the time, Dr. Seymour Kalter, the Marburg virus was apparently manmade. 23-25
In fact, Litton Bionetics, the chief military and industrial supplier of primates for cancer virus experimentation during the 1960s and early 1970s, also maintained the colony of the specific genus of monkeys associated with all of the major monkey AIDS virus outbreaks in the United States. 23
Through telephone interviews with Litton Bionetics and MedPath administrators, I learned that Bionetics Research Laboratories had been sold to MedPath Corporation—one of America's largest medical and blood testing laboratories—a division of Dow Corning. Dow Coming's parent, Dow Chemical Company, was also listed among the Army's chief biological weapons contractors during the 1960s and early 1970s. 26,27 Litton Bionetics, a subsidiary of Litton Industries, Inc. remains in business as a proprietor of the Frederick Cancer Research Center, a "privately owned, government contracted" facility. Bionetics, it was noted,
Similar Books
